ScholarGate
Assistent

Methoden vergleichen

Prüfen Sie die ausgewählten Methoden nebeneinander; abweichende Zeilen sind hervorgehoben.

Rom IV-Diagnosekriterien für das Reizdarmsyndrom×Kurzfragebogen zu Chronisch-Entzündlichen Darmerkrankungen (IBDQ-32)×
FachgebietGastroenterologieGastroenterologie
FamilieProcess / pipelineProcess / pipeline
Entstehungsjahr20162004
UrheberRome Foundation (multinational expert consensus)Guyonnet, D., Chassany, O., Ducroc, R., et al.
TypDiagnostic CriteriaSelf-report
Wegweisende QuelleMearin, F., Lacy, B. E., Chang, L., et al. (2016). Bowel disorders. Gastroenterology. Published online June 2016 by the Rome Foundation. link ↗Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465. link ↗
AliasnamenRome IV IBS, Rome CriteriaIBDQ-32, Short IBDQ
Verwandt44
ZusammenfassungThe Rome IV criteria are the internationally accepted diagnostic standard for irritable bowel syndrome (IBS), published in 2016 by the Rome Foundation. These criteria define IBS as recurrent abdominal pain (≥1 day per week for ≥3 months) associated with altered bowel habits, without structural or biochemical abnormalities. IBS is subtyped into four patterns—IBS-constipation predominant (IBS-C), IBS-diarrhea predominant (IBS-D), IBS-mixed (IBS-M), and IBS-unclassified (IBS-U)—based on stool consistency patterns.The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.
ScholarGateDatensatz
  1. v1
  2. 1 Quellen
  3. PUBLISHED
  1. v1
  2. 1 Quellen
  3. PUBLISHED

Zur Suche Folien herunterladen

ScholarGateMethoden vergleichen: Rome IV Irritable Bowel Syndrome Criteria · Short Inflammatory Bowel Disease Questionnaire. Abgerufen am 2026-06-20 von https://scholargate.app/de/compare